BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

804 related articles for article (PubMed ID: 20448470)

  • 1. Development of improved vaccines against whooping cough: current status.
    Marzouqi I; Richmond P; Fry S; Wetherall J; Mukkur T
    Hum Vaccin; 2010 Jul; 6(7):543-53. PubMed ID: 20448470
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bordetella Pertussis virulence factors in the continuing evolution of whooping cough vaccines for improved performance.
    Dorji D; Mooi F; Yantorno O; Deora R; Graham RM; Mukkur TK
    Med Microbiol Immunol; 2018 Feb; 207(1):3-26. PubMed ID: 29164393
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Do we need a new vaccine to control the re-emergence of pertussis?
    Mills KH; Ross PJ; Allen AC; Wilk MM
    Trends Microbiol; 2014 Feb; 22(2):49-52. PubMed ID: 24485284
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Resurgence of pertussis calls for re-evaluation of pertussis animal models.
    van der Ark AA; Hozbor DF; Boog CJ; Metz B; van den Dobbelsteen GP; van Els CA
    Expert Rev Vaccines; 2012 Sep; 11(9):1121-37. PubMed ID: 23151168
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Re-emergence of pertussis: what are the solutions?
    Libster R; Edwards KM
    Expert Rev Vaccines; 2012 Nov; 11(11):1331-46. PubMed ID: 23249233
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Changing pertussis epidemiology: everything old is new again.
    Clark TA
    J Infect Dis; 2014 Apr; 209(7):978-81. PubMed ID: 24626532
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pertussis vaccination and whooping cough: and now what?
    Guiso N
    Expert Rev Vaccines; 2014 Oct; 13(10):1163-5. PubMed ID: 25020131
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bordetella pertussis pathogenesis: current and future challenges.
    Melvin JA; Scheller EV; Miller JF; Cotter PA
    Nat Rev Microbiol; 2014 Apr; 12(4):274-88. PubMed ID: 24608338
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bordetella pertussis and vaccination: the persistence of a genetically monomorphic pathogen.
    Mooi FR
    Infect Genet Evol; 2010 Jan; 10(1):36-49. PubMed ID: 19879977
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Different T cell memory in preadolescents after whole-cell or acellular pertussis vaccination.
    Smits K; Pottier G; Smet J; Dirix V; Vermeulen F; De Schutter I; Carollo M; Locht C; Ausiello CM; Mascart F
    Vaccine; 2013 Dec; 32(1):111-8. PubMed ID: 24176499
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pertussis resurgence: perspectives from the Working Group Meeting on pertussis on the causes, possible paths forward, and gaps in our knowledge.
    Burns DL; Meade BD; Messionnier NE
    J Infect Dis; 2014 Apr; 209 Suppl 1():S32-5. PubMed ID: 24626870
    [No Abstract]   [Full Text] [Related]  

  • 12. Impact of infant and preschool pertussis vaccinations on memory B-cell responses in children at 4 years of age.
    Hendrikx LH; de Rond LG; Oztürk K; Veenhoven RH; Sanders EA; Berbers GA; Buisman AM
    Vaccine; 2011 Aug; 29(34):5725-30. PubMed ID: 21669247
    [TBL] [Abstract][Full Text] [Related]  

  • 13. JMM Profile:
    Fry NK; Campbell H; Amirthalingam G
    J Med Microbiol; 2021 Oct; 70(10):. PubMed ID: 34668853
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Licensed pertussis vaccines in the United States. History and current state.
    Klein NP
    Hum Vaccin Immunother; 2014; 10(9):2684-90. PubMed ID: 25483496
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pertussis: pertussis control strategies and the options for improving current vaccines.
    Plotkin SA
    Expert Rev Vaccines; 2014 Sep; 13(9):1071-2. PubMed ID: 25090359
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Possible options for new pertussis vaccines.
    Meade BD; Plotkin SA; Locht C
    J Infect Dis; 2014 Apr; 209 Suppl 1():S24-7. PubMed ID: 24626868
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pertussis: challenges today and for the future.
    Cherry JD
    PLoS Pathog; 2013; 9(7):e1003418. PubMed ID: 23935481
    [No Abstract]   [Full Text] [Related]  

  • 18. Acellular pertussis vaccines and pertussis resurgence: revise or replace?
    Ausiello CM; Cassone A
    mBio; 2014 Jun; 5(3):e01339-14. PubMed ID: 24917600
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Global population structure and evolution of Bordetella pertussis and their relationship with vaccination.
    Bart MJ; Harris SR; Advani A; Arakawa Y; Bottero D; Bouchez V; Cassiday PK; Chiang CS; Dalby T; Fry NK; Gaillard ME; van Gent M; Guiso N; Hallander HO; Harvill ET; He Q; van der Heide HG; Heuvelman K; Hozbor DF; Kamachi K; Karataev GI; Lan R; Lutyńska A; Maharjan RP; Mertsola J; Miyamura T; Octavia S; Preston A; Quail MA; Sintchenko V; Stefanelli P; Tondella ML; Tsang RS; Xu Y; Yao SM; Zhang S; Parkhill J; Mooi FR
    mBio; 2014 Apr; 5(2):e01074. PubMed ID: 24757216
    [TBL] [Abstract][Full Text] [Related]  

  • 20. What to do about pertussis vaccines? Linking what we know about pertussis vaccine effectiveness, immunology and disease transmission to create a better vaccine.
    Bolotin S; Harvill ET; Crowcroft NS
    Pathog Dis; 2015 Nov; 73(8):ftv057. PubMed ID: 26253079
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 41.